PharmaTimes | in-depth news, features and insights for the pharmaceuti...
Pharma Times. The once-daily, fixed-dose treatment demonstrated significant improvements in lung function and asthma control..
Read Pharmatimes.com news digest here: view the latest Pharma Times articles and content updates right away or get to their most visited pages. Pharmatimes.com belongs to a group of fairly successful websites, with more than 30K visitors from all over the world monthly. It seems that Pharma Times content is notably popular in USA, as 26% of all users (7.8K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Pharmatimes.com and thus you can safely use it. Pharmatimes.com is hosted with Pressable (United States) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
999
Visitors daily -
999
Pageviews daily -
5
Google PR -
36 676
Alexa rank
Best pages on Pharmatimes.com
-
PharmaTimes – in-depth news, features and insights for the pharmaceutical and healthcare sectors
The PharmaTimes portfolio includes the well-respected monthly PharmaTimes Magazine; three news elert services; business forums, where thought-leaders meet to discuss the issues of the day; and a serie...
-
Sanofi touts pipeline with 18 new drugs by 2020 - PharmaTimes
Sanofi, which sensationally sacked chief executive Chris Viehbacher at the end of last month, says it expects to launch up to 18 new drugs over the next seven years, which could generate more than 30 ...
-
Long-term data back safety of GSK's asthma biologic - PharmaTimes
GlaxoSmithKline has unveiled new safety and efficacy data for its asthma biologic Nucala, showing that the drug’s risk/benefit profile was maintained over an extended 52-week period. - News - PharmaT...
Pharmatimes.com news digest
-
3 months
Immune cell helps predict skin cancer patients’ responses to immunotherapies
Vd1-gd T cells were effective in predicting positive responses to ICI therapy
-
3 months
Owkin and Evotec partner to accelerate therapeutics in oncology and I&I
The companies will aim to select targets, discover and develop new therapeutics
-
3 months
Disrupted sleep could be associated with cognitive function changes
High amounts of disrupted sleep were found to affect memory and thinking performance
-
3 months
Risk model predicts response and survival of cancer patients treated with ICIs
Metastatic cancer is estimated to be responsible for 90% of cancer deaths
Domain history
| Web host: | Pressable |
| Registrar: | Tucows Domains Inc. |
| Registrant: | REDACTED FOR PRIVACY |
| Updated: | February 22, 2024 |
| Expires: | March 23, 2025 |
| Created: | March 23, 2000 |
Whois record
Visitor gender
Male
Female
Safety scores
Trustworthiness
ExcellentChild safety
N/A
